Vidal, S.; Puig, L.; Carrascosa-Carrillo, J.-M.; González-Cantero, Á.; Ruiz-Carrascosa, J.-C.; Velasco-Pastor, A.-M.
Correction: Vidal et al. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Int. J. Mol. Sci. 2021, 22, 6740. Int. J. Mol. Sci. 2022, 23, 2649.
https://doi.org/10.3390/ijms23052649
AMA Style
Vidal S, Puig L, Carrascosa-Carrillo J-M, González-Cantero Á, Ruiz-Carrascosa J-C, Velasco-Pastor A-M.
Correction: Vidal et al. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Int. J. Mol. Sci. 2021, 22, 6740. International Journal of Molecular Sciences. 2022; 23(5):2649.
https://doi.org/10.3390/ijms23052649
Chicago/Turabian Style
Vidal, Silvia, Lluís Puig, José-Manuel Carrascosa-Carrillo, Álvaro González-Cantero, José-Carlos Ruiz-Carrascosa, and Antonio-Manuel Velasco-Pastor.
2022. "Correction: Vidal et al. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Int. J. Mol. Sci. 2021, 22, 6740" International Journal of Molecular Sciences 23, no. 5: 2649.
https://doi.org/10.3390/ijms23052649
APA Style
Vidal, S., Puig, L., Carrascosa-Carrillo, J. -M., González-Cantero, Á., Ruiz-Carrascosa, J. -C., & Velasco-Pastor, A. -M.
(2022). Correction: Vidal et al. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Int. J. Mol. Sci. 2021, 22, 6740. International Journal of Molecular Sciences, 23(5), 2649.
https://doi.org/10.3390/ijms23052649
